The opening of the Brás Cubas clinic reflects Diaverum's continued commitment to expanding access to high-quality kidney care across Latin America. By investing in capacity, clinical expertise and strong partnerships with local healthcare systems, we are enabling more patients to access life-sustaining treatment while supporting the long-term development of healthcare services in the communities we serve.

Our commitment to Mogi das Cruzes is long-term and rooted in the needs of the community. By expanding treatment capacity and creating additional availability within the public healthcare system, we are helping more patients access high-quality care closer to home. At the same time, we are strengthening the region's healthcare infrastructure to meet future needs and support better outcomes for patients and families.

The opening of the Brás Cubas clinic is an important step in strengthening access to high-quality kidney care in the region. By combining modern facilities, advanced technology and experienced multidisciplinary teams, we are creating an environment that supports safe, effective and patient-centred treatment. Most importantly, this investment will help more patients access the care they need closer to home while supporting better outcomes and quality of life for people living with chronic kidney disease.

We believe renal care goes beyond treatment to enabling fuller, healthier lives. As healthcare systems worldwide seek more sustainable and equitable ways to deliver care, Diaverum is stepping forward to lead the transformation of renal care. In 2025, we moved beyond building foundations to demonstrating measurable progress across our ESG priorities. A defining driver of this progress is our deeper integration within M42. This is accelerating how we deliver care – combining Diaverum’s clinical expertise with advanced capabilities in data, AI and precision health to enable more connected, predictive and personalised care at scale. Together, we are expanding access to kidney care, helping to improve outcomes and support healthcare systems to become more sustainable and resilient globally

Our 2025 ESG report reflects a year of meaningful progress across all pillars of our framework. We have moved from setting ambitions to delivering measurable outcomes, embedding sustainability more deeply into how we operate and how we make decisions. As Diaverum continues to deepen its integration with M42, we remain focused on continuous improvement and on delivering long-term, responsible growth for our patients, our people and the communities we serve.

São Paulo is one of the most important healthcare markets in Brazil, with strong and growing demand for high-quality healthcare services.  This acquisition allows us to expand access to life-enhancing renal care for more patients and strengthen our role in the communities we serve.

Latin America remains a key region in Diaverum’s long-term development strategy. Strengthening our presence in São Paulo state increases regional market presence, enhances clinical collaboration and builds a more connected network of care. This expansion allows us not only to grow dialysis capacity, but also to further support integrated chronic disease management. By embedding our Care Delivery Model and leveraging digital tools, we are better positioned to enable earlier intervention and improved care coordination for patients living with complex conditions such as diabetes and chronic kidney disease.

Brazil is a strategic market for Diaverum given its scale, long-term g​rowth potential and the opportunity to continue advancing standards within a fragmented dialysis landscape. Expanding in São Paulo state - the country’s most economically dynamic region - reinforces our ability to deliver consistently high-quality, patient-centered renal care at scale.

We are proud to expand our presence in Hamburg with this new clinic, which reflects our commitment to delivering life-enhancing renal care to more patients in the region. Located in the city’s most populous district, the centre will help meet the growing demand for specialised kidney care while enabling more patients to access the treatment they need to lead fulfilling lives.

At Diaverum, we are committed to delivering the highest quality of care in every country in which we operate. The opening of this new state-of-the-art clinic marks an important step in our global strategy to expand access to world-class renal care.  Through our integrated, digitally supported care model, we aim to improve patient outcomes and quality of life while continuously raising the standards of renal care.

Expanding our capacity in Chile is part of our mission, but our true focus remains on enhancing the continuity and quality of care for every patient. By integrating these new clinics into our network, we will implement Diaverum’s standardised medical protocols, continuous training programs, and digital tools, so our team of medical experts can support the physical, emotional, and social well-being of patients in the region.

The Valparaíso region is a thriving regional hub with growing demand for specialised healthcare. The acquisition of these clinics allows us to expand our presence in central Chile through mature and well-managed clinics with a strong track record of quality care, which share Diaverum’s values: patient-centred care, clinical excellence, and a commitment to innovation

This acquisition strengthens our position in a key region of Chile, advancing Diaverum’s mission of delivering high-quality, life-enhancing care in every community we serve. Our holistic approach, rooted in clinical excellence and supported by our digital infrastructure and innovative solutions, will enable us to deliver world-class, personalised care to more patients in need.

The opening of two new centres in Jaén allows us to bring to more patients a comprehensive care programme based on clinical excellence, human support throughout the entire treatment process, and technological innovation, promoting their physical, emotional, and social well-being.

This new award reflects our experience and leadership in the region, as well as a perfect opportunity to continue bringing our multidisciplinary and personalised care model to more patients in Andalusia.

This award not only strengthens our position as a national and Andalusia benchmark and leader in outpatient dialysis but also reflects our vision of sustainable, patient-centred growth. It reinforces our commitment to growing responsibly, generating value for the public healthcare system and ensuring first-class care for all patients in the provinces and regions where we operate.

Spain is one of our most important markets, and this new expansion in Jaén underlines our long-term commitment to providing best-in-class renal care to patients worldwide. By investing in new, modern facilities and expanding our network, we are not only strengthening our leadership in Spain but also advancing Diaverum’s mission of delivering high-quality, patient-centred care in every community we serve.

Ribeirão Preto is a thriving regional hub with growing demand for specialised healthcare. The acquisition of SENERP allows us to expand our presence in the interior of São Paulo through a mature and well-managed clinic that shares Diaverum’s values: patient-centered care, clinical excellence, and a commitment to innovation.

SENERP brings together a highly skilled clinical team, robust infrastructure, and a strong track record of quality care. This acquisition strengthens our position in the Southeast region and opens new opportunities for collaboration with private payers, enabling us to deliver integrated, patient-specific renal care across all treatment pathways.

Expanding capacity is just one part of our mission – our focus remains on improving care quality and continuity for every patient. By integrating SENERP into our network, we will deploy Diaverum’s standardised medical protocols, continuous training programmes, and digital tools, building a more efficient and compassionate renal care ecosystem.

This new partnership exemplifies the best of what public-private collaboration can achieve — bringing together our clinical expertise, digital capabilities and True care culture to support the Spanish health system in delivering world-class renal care. It is an honour to contribute to improving the lives of even more patients in Andalusia, and to do so in close partnership with the local health authorities.

This development not only reinforces our leadership in Spain's renal care sector but also reflects our vision for sustainable, patient-centred growth. It is a testament to our continued commitment to supporting public healthcare systems and ensuring high-quality care to all the patients across the regions we operate.

The launch of these four clinics will allow us to implement a comprehensive care delivery model rooted in clinical excellence, technological innovation, and compassionate support - enhancing our patients’ physical, emotional, and social well-being throughout their treatment journey

This acquisition is another important step in our commitment to enhancing the lives of people with kidney disease, by offering world-class renal care underpinned by our innovative, digital solutions. By expanding our presence in Portugal’s central region, we are ensuring that more patients have access to high-quality treatment closer to home, while reinforcing our promise of True care to every patient, every day.

It is a great honour for Diaverum Portugal to be entrusted by the founders of Nefropinhal to carry on their legacy and welcome the clinic into our network. We recognise the vital role this clinic plays in the local community, and we are committed to ensuring that patients in Sertã continue to receive high-quality care close to home, supported as always by our True care culture. At the same time, we look forward to supporting the clinic’s dedicated team, offering them the opportunity to grow within a global organisation that values their expertise and dedication.

As global demand for dialysis grows, we remain focused on providing life-enhancing renal care - wherever and whenever it is needed. ESG is increasingly shaping our strategy, decisions, and culture, ensuring we serve not only our patients, but also the communities and planet we all depend on. Our ESG journey is grounded in the belief that responsible, sustainable healthcare is not only possible - but essential. Together with M42, we are broadening access to kidney care, improving outcomes, and helping build more resilient, sustainable healthcare systems.

Throughout 2024, we focused on embedding sustainability more deeply into our core strategy and daily operations. This report is a testament to the collective efforts of our teams across 24 countries. It also reflects our ongoing commitment to transparency and best practice reporting. While we are proud of our progress, we remain committed to growing responsibly and further minimising our environmental impact.

Since 2017, Diaverum has ambitiously expanded its footprint in Brazil, focusing on regions with growing populations and unmet medical needs. We are committed to enhancing the lives of people with chronic kidney disease, by offering world-class care, supported by our digital infrastructure and innovative solutions. The integration of the UNTR clinic is not only a strategic milestone, but a reflection of our purpose: to make high-quality care accessible to more patients, where and when they need it most.

The integration of the UNTR clinic into our portfolio marks an important step forward in advancing our long-term strategy in Greater São Paulo. This is a region where population growth and healthcare demand continue to rise – and where the need for reliable, high-quality renal care is critical. By strengthening our presence here, we are not only expanding access but also building meaningful partnerships with public and private stakeholders to serve patients across all care pathways.

Increasing capacity is only part of the equation – our true focus is on improving the quality and continuity of care for every patient. The UNTR clinic brings strong clinical foundations and a shared culture of patient-centred care, which we will enhance further through Diaverum’s standardised medical protocols, training programmes, and digital tools. This is another important step toward a more integrated and efficient renal care system in Brazil.

The integration of Diaverum Renal Services Sdn Bhd into our clinic network reinforces our commitment to transforming renal care and growing our offering in Asia, a region with a high prevalence of chronic kidney disease. Our holistic care approach, combined with our digital infrastructure and innovative solutions, will enable us to deliver world-class, personalised care to more patients in need.

The acquisition of IMU Dialysis marks a major milestone as our first-ever acquisition in Malaysia since entering the market. While we have been managing this clinic operationally for the past 11 years, this move represents a formal investment into the local market. It strengthens our footprint in the region and reinforces our long-term vision for sustainable growth in South-East Asia. We are proud of this achievement and grateful to everyone involved in the process. This is an exciting new chapter for Diaverum Malaysia.

Rafael’s inspiring leadership, deep understanding of the business, and unwavering commitment to care excellence, innovation, and sustainable growth make him the right person to lead Diaverum into its next chapter. His appointment ensures that the company remains firmly committed to its mission of delivering life-enhancing renal care, while also supporting national healthcare systems to manage the growing burden of chronic conditions. I am immensely proud of what we have achieved together at Diaverum over the past seven years and equally excited about the future under Rafael’s leadership

Diaverum’s journey has been one of sustainable growth and transformation, into a leading global renal care provider, distinguished by our unparalleled patient care, pioneering digital & AI capabilities, and strong brand identity. Since 2008, we have added 264 clinics, entered 14 new markets, more than quadrupled our patient base and, more importantly, consistently improved our Clinical Performance Measurement scores year-on-year, achieving an all-time high in 2024. I am committed to building on this legacy, accelerating both organic and inorganic growth, and expanding access to high-quality renal care for underserved communities – because everyone deserves a fulfilling life. Together with our teams around the world, we will continue to deliver meaningful outcomes for patients, communities, and health systems, while creating sustainable value for our strategic investor.

Diaverum’s acquisition of the two clinics in Germany marks a significant milestone in our mission to expand access to high-quality renal care in the region. As part of our commitment to transforming global healthcare, we continue to grow our footprint, with innovative, patient-centric solutions. This expansion not only strengthens Diaverum’s presence in Europe but also reinforces our dedication to improving lives through cutting-edge, integrated healthcare solutions.

We are committed to providing life-enhancing renal care to patients in Germany, because everyone deserves a fulfilling life. To achieve this, we offer the entire spectrum of nephrology services, ranging from preventive care and hemodialysis to the management of comorbidities and transplant care, as part of Diaverum’s holistic approach to renal care. We are excited to serve more patients, ensuring the highest standards of medical excellence and care.

We are delighted to bring Diaverum to Abu Dhabi and Al-Ain, and look forward to seeing it commence on-the-ground operations in the near future. Now well-established and integrated with the M42 Group, Diaverum is ideally positioned to take advantage of its portfolio’s combined health-tech capabilities, high standards of care delivery, multi-disciplinary services and international network, to transform the UAE’s CKD landscape, with its life-enhancing renal care offering.

I am honoured to welcome the UAE to our Diaverum family. Today’s announcement marks a significant milestone in our mission to transform renal care worldwide, and grow our offering in the Middle East, a region that is feeling the escalating healthcare burden of CKD to patients, communities and national health care systems. By combining our excellence in care standards and expertise in AI-enabled, personalised renal care, with the integration of M42's extensive patient care platform & strong local presence, we have great ambitions to create a future-ready renal care landscape in the UAE, characterised by innovation, quality, and sustainability.

This partnership marks a significant milestone in our mission to transform renal care in Greece. By combining Diaverum’s excellence in care standards and expertise in AI-enabled, personalised renal care, with BIOIATRIKI’s extensive collaborators' network, advanced diagnostic services, & strong local presence, we aim to deliver transformative solutions for dialysis patients, enabling access to world-class care.

We are delighted to have entered into this agreement with Diaverum, a global leader in quality renal care services and a company that has swiftly established a strong and dynamic presence in Greece's renal care sector. This partnership reflects our Group's commitment, since our establishment in 1981, to delivering world-class healthcare services to our patients.

We are thrilled to be entering this agreement with BIOIATRIKI, which is driven by our shared vision to transform dialysis care. In combining BIOIATRIKI’s strong local presence with Diaverum’s global expertise and innovative digital technologies, we look forward to empowering patients to live fulfilling lives, together.

These are exciting times for Brazil and represent a significant milestone in our growth plan in the country. We are committed to enhancing the lives of people with kidney disease by offering world-class care supported by our innovative, digital solutions. Additionally, we are dedicated to broadening access to the highest quality of care by opening clinics in areas with high need.

This highly-strategic move marks a critical step in our mission to deliver high-quality renal care to even more patients. It will significantly increase our capacity in both regions and enable us to continue providing life-enhancing renal care to a growing number of patients.

By expanding our capacity and introducing a multidisciplinary approach, we are not only addressing the growing demand for haemodialysis but also enhancing the overall patient experience. Our commitment remains on providing comprehensive, patient-centred care, ensuring that every individual receives the best possible treatment and support.

We are thrilled to announce the inclusion of Woodgate Dialysis Unit to our portfolio of clinics, which represents a significant milestone in our ongoing commitment to providing exceptional healthcare to our communities. The dialysis centre is designed to offer comprehensive, patient-centred care, leveraging the latest medical advancements and technologies. Our dedicated team of nursing professionals is excited to serve our patients in a comfortable and modern environment, ensuring the highest standards of medical excellence and compassionate care.

I am excited and proud in equal measure about our new offering. Travel – and more specifically, freedom of movement - is an essential part of life; it’s not only about exploring new destinations but also about being able to connect with friends and family in other cities or countries. Patients who are on a transplant waiting list are on call 24/7 and must be able to reach the transplant centre within a short window of time once they are notified a kidney is available for them. Our d.HOLIDAY Fly Back Programme will give these patients the confidence to travel with piece of mind at such an important moment in their lives.

I am delighted that d.HOLIDAY, an incredibly valuable service available to people living with CKD, is now supporting the mobility of dialysis patients on their long-awaited and highly emotional journey towards transplantation. As both a nephrologist and kidney donor, I’ve had the privilege to witness the profound difference receiving a kidney can make in empowering CKD patients to live fulfilling lives. That d.HOLIDAY understands and supports this, is proof that Diaverum is an organisation with True care at the core of everything it does.

There is a growing awareness of the environmental impact of healthcare. If the global healthcare industry were a country, it would be the world’s fifth largest contributor to carbon emissions. When it comes to renal care, dialysis is not only a lifetime burden to patients, but also a significant burden to the environment. With that in mind, we are tackling the environmental impact of our operations head on, articulating a new environmental strategy to lead us to Net Zero by 2050. Our provision of life-enhancing renal care to patients around the world creates a platform from which we can reduce our environmental footprint while improving medical outcomes and the well-being of the people we care for, in a true win-win situation.

We truly believe that private companies’ ethical operating principles and sustainable business models can create shared value that benefit society, while safeguarding the environment in which we live. Reflecting on Diaverum’s ESG journey to date, I am inspired by both the progress made and the challenges ahead. With dedication to our patients, employees,partners and the wider society in which we operate as our constant, I am confident that Diaverum is poised to drive positive change, shaping a more sustainable future for the healthcare industry and beyond. All of this is shared in detail in our 2023 ESG Report, which I invite you to read.

This latest win is fantastic news for Diaverum and serves to underscore the growth trajectory we’re on in the UK. There were a number of our competitors involved in what was a highly competitive tender. Our bid – combining best-in-class care at the right pricing - was clearly a compelling and winning offer. Many thanks to everyone involved for this tremendous win.